US Patent Issued to Regeneron Pharmaceuticals on March 17 for "Treatment of glaucoma with Rho Guanine Nucleotide Exchange factor 12 (ARHGEF12) inhibitors" (New York Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,562, issued on March 17, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Treatment of glaucoma with Rho Guanine Nucleotide Exchange factor 12 (ARHGEF12) inhibitors" was invented by Kavita Praveen (Tarrytown, N.Y.), Giovanni Coppola (Tarrytown, N.Y.), Manuel Allen Revez Ferreira (Tarrytown, N.Y.), Lauren Gurski (Tarrytown, N.Y.), Aris Baras (Tarrytown, N.Y.) and Claudia Schurmann (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of treating subjects having glaucoma or elevated intraocular pressure (IOP), methods of identifying subjects having an increased risk of developing gla...